ACS
0.06
361.5%
ERA
0.002
-33.3%
PET
0.026
271.4%
SFG
0.002
-33.3%
C1X
0.105
36.4%
CDR
0.015
-25%
QFE
0.079
33.9%
FHS
0.003
-25%
AT1
0.034
25.9%
AVE
0.008
-20%
ATH
0.01
25%
GLL
0.008
-20%
TYX
0.005
25%
OEL
0.004
-20%
IVX
0.096
21.5%
RLG
0.004
-20%
EPXDA
0.2
21.2%
CZN
0.15
-16.7%
MRZ
0.32
20.8%
TEM
0.005
-16.7%
APC
0.012
20%
ZEU
0.01
-16.7%
GEN
0.012
20%
KNG
0.105
-16%
COS
0.5
19%
NNL
0.175
-14.6%
AEU
0.38
18.8%
GES
0.006
-14.3%
EUR
0.195
18.2%
LMG
0.024
-14.3%
CMA
1.82
17.4%
PAB
0.03
-14.3%
CPN
0.11
17%
TGH
0.024
-14.3%
HCT
0.09
16.9%
XPN
0.012
-14.3%
COV
0.73
16.8%
RB6
0.099
-13.9%
PDI
0.73
16.8%
IMI
0.013
-13.3%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Interviews

As enterprises across Asia Pacific accelerate their shift toward AI-powered digital engagement, Vection Technologies (ASX:VR1, OTC:VCTNY, FRA: S1X) is expanding its footprint with a disciplined, earnings-accretive strategy. The Company has executed a binding offer to acquire Monogic Limited, a high-performing Hong Kong and Singapore digital marketing and brand experience agency, delivering strong EBITDA margins and deep relationships with major blue-chip clients. Joining The Stock Network’s Lel Smits, Lorenzo Biagi, Executive Director reveals how the acquisition strengthens Vection’s integrated digital transformation offering across immersive XR, AI and creative communications. 1. Transforming APAC digital engagement How does Monogic strengthen Vection’s digital engagement offering across APAC? 2. Integrated digital engagement platform What new solutions become possible by combining Monogic’s creative services with Vection’s XR and AI tech? 3. APAC expansion with blue-chip access How does Monogic’s presence in Hong Kong and Singapore accelerate Vection’s regional growth? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
Vection Technologies (ASX:VR1, OTC:VCTNY, FRA:S1X): Accelerating APAC expansion
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS5BRjY4NjdBRjA5RTdCMUMx

Vection Technologies (ASX:VR1, OTC:VCTNY, FRA:S1X): Accelerating APAC expansion

Venari Minerals NL (ASX:VMS) has reported another set of assay results from its October RC drilling program at the Red Mountain Lithium Project in Nevada, describing them as “outstanding”. The latest four drill holes delivered multiple thick, high-grade lithium zones and complete the full drilling dataset for the project’s central zone, paving the way for next month’s maiden Mineral Resource Estimate. Executive Director and CEO Matt Healy joins The Stock Network’s Lel Smits to discuss how these results strengthen Red Mountain’s scale potential and set up a catalyst-rich finish to the year. 1. Thick, high-grade lithium across the central zone This second batch of results includes standout intersections. How do these new hits build on the earlier results and what do they reveal about the continuity and quality of mineralisation in the central zone? 2. Complete dataset ahead of the maiden Resource With the central zone now fully drilled and these results confirming strong widths and grades, how does this finalised dataset shape your expectations heading into the maiden Mineral Resource Estimate next month, and what should investors look for as assays from the northern zone arrive? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
Venari Minerals (ASX:VMS): Lithium hits add to Red Mountain dataset ahead of maiden Resource
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS41RjU0OTVCQThDNUUwQzBD

Venari Minerals (ASX:VMS): Lithium hits add to Red Mountain dataset ahead of maiden Resource

Pengana Private Equity Trust (ASX:PE1) gives investors rare access to global private markets through a single listed vehicle. Managed by Grosvenor Capital Management L.P., one of the world’s longest-operating alternative investment allocators, Pengana Private Equity Trust offers diversified exposure to private equity, private credit and opportunistic investments. Joining The Stock Network’s Lel Smits, Executive Director Adam Myers explains how Pengana Private Equity Trust opens the door to global private companies and long-term growth opportunities. 1. Accessing global private markets Pengana Private Equity Trust gives investors exposure to the kind of private equity usually reserved for institutions. How does Pengana Private Equity Trust make institutional quality private equity accessible for everyday investors? 2. Diversification across global private companies The Trust spans multiple strategies, sectors and geographies through Grosvenor’s platform. Which portfolio companies or themes best highlight Pengana Private Equity Trust’s global diversification? 3. Listed structure, long-term value and outlook Pengana Private Equity Trust combines private market exposure with ASX liquidity. Why is listed private equity an effective long-term addition to modern portfolios and what's your outlook for the year ahead? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
Pengana Private Equity Trust (ASX:PE1): Accessing global private equity on ASX
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS5EREU0QjZERDMzRDBGNTMz

Pengana Private Equity Trust (ASX:PE1): Accessing global private equity on ASX

EBR Systems Inc (ASX:EBR) is the developer of the world’s only wireless cardiac pacing technology, the WiSE® System, designed to revolutionise treatment for heart failure patients who require cardiac resynchronization therapy (CRT). With the WiSE-UP Study now underway, EBR Systems is generating long-term real-world performance data to further validate the benefits of left-ventricular endo-cardial pacing and strengthen adoption of the WiSE® System globally. Joining The Stock Network’s Lel Smits, John McCutcheon, President & CEO of EBR Systems, shares how this major milestone positions the company for future commercial acceleration. 1. A major milestone in global CRT innovation EBR has just announced the first two patients enrolled in the WiSE-UP Study, a landmark moment in advancing wireless CRT. How significant is this milestone for EBR Systems and for the clinicians treating heart failure patients? 2. Generating real-world performance data at scale WiSE-UP will follow more than 300 patients across 50 US centers over five years, capturing real-world outcomes using the FDA-approved WiSE® System. What key insights do you expect this study to deliver, and why is real-world data so important for driving adoption of new cardiac technologies? 3. Improving patient outcomes through wireless pacing Clinicians leading the study have already described the WiSE® System as a step-change in cardiac resynchronization therapy. How does the WiSE® System improve on traditional CRT devices, and what patient groups stand to benefit the most from wireless endocardial pacing? 4. Building long-term commercial momentum With FDA approval and US commercial rollout underway, the WiSE-UP Study will provide clinical evidence to support broader adoption. How will this study support your commercial strategy, and what are the next steps as EBR expands across the US and internationally? 5. Quarterly earnings I see you’ve just released your quarterly earnings. How are you feeling about the results and what were the highlights? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
EBR Systems (ASX:EBR): Advancing CRT with real-world clinical evidence
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS5CNEFEOUNDRUMzMjVGMjc2

EBR Systems (ASX:EBR): Advancing CRT with real-world clinical evidence

Alice Queen Limited (ASX:AQX) is an Australian gold and copper explorer with high-grade opportunities across Fiji and on Horn Island, in Far North Queensland, Australia. The September Quarter delivered strong momentum and a strategic review underway to unlock value at Horn Island. The Company has also recently raised $1 million and appointed mining lawyer Paul Williams to the Board. Managing Director Andrew Buxton speaks with The Stock Network’s Lel Smits ahead of the Stocks on Location investor event in Melbourne. 1. Horn Island: Value uplift in rising gold price As gold prices surge from ~A$2,450/oz at the time of the 2021 Scoping Study to around A$6,000/oz today, how is Alice Queen reassessing Horn Island economics? What steps are involved in refreshing the Scoping Study and preparing for funding or development? 2. Fiji: Expanding high-grade gold system Viani continues to return strong surface sampling, extending strike length to around 5km and confirming high-grade epithermal gold. Can you outline latest assays, how results guide drilling plans, and potential for a maiden resource? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
Alice Queen (ASX:AQX): Advancing the development of the Horn Island gold project
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS45NDIzMEVBNjk5NTFGRDZC

Alice Queen (ASX:AQX): Advancing the development of the Horn Island gold project

Electro Optic Systems (ASX:EOS) is rapidly scaling as a global technology leader in advanced defence systems, counter-drone solutions and space domain capabilities. With major contracts secured across Australia, Europe and the United States, EOS is executing on its commercial strategy, driving revenue growth, product deployment and strong global demand for its technology. Joining The Stock Network’s Lel Smits, Dr Andreas Schwer, Managing Director and Chief Executive Officer of EOS, discusses how the company is accelerating commercial traction across defence and space, backed by a contract backlog of $415 million, world-first product deployments, and a balance sheet with $91.5 million in cash. 1. Winning landmark contracts including a world-first High Energy Laser export order EOS secured a €71.4 million (A$125 million) order from a NATO member state, the first time a 100 kilowatt High Energy Laser Weapon has ever been exported globally. What does this contract mean for EOS commercially, and how does it position the company in the rapidly growing directed-energy weapons market? 2. Expanding global partnerships and delivering on major defence programs EOS has also won a $108 million LAND 400-3 contract with Hanwha Australia to supply enhanced R400 Remote Weapon Systems. How does this partnership strengthen EOS’s footprint in the Australian defence ecosystem, and what does it mean for future pipeline opportunities? 3. Building a $415 million backlog and delivering new orders across Australia, Europe and the US The quarterly backlog rose to $415 million, up 206% since December 2024, driven by strong demand for counter-drone and heavy-calibre weapons. What is driving this surge in global demand, particularly in the US where EOS won US$8.5 million in new orders for Slinger and R800 systems? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
Electro Optic Systems (ASX:EOS): Rapidly scaling next-gen defence & space tech to global markets
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS5CODNEOTFERDNCQjU2ODhE

Electro Optic Systems (ASX:EOS): Rapidly scaling next-gen defence & space tech to global markets

EBR Systems Inc (ASX:EBR) is building a fast-growing medical device company with the world’s only leadless pacemaker that is revolutionising heart failure treatment. The Silicon Valley-based company's groundbreaking WiSE™ CRT System delivers wireless pacing inside the heart. This is a major leap forward from traditional pacemakers that rely on wires and leads. Joining The Stock Network’s Lel Smits, Andrew Shute, Chief Corporate Development Officer at EBR Systems, discusses how the company’s “go slow to grow fast” strategy is positioning EBR Systems to capture a share of the US$3.6 billion addressable market for cardiac resynchronisation therapy (CRT). 1. Solving lead-related complications in heart rhythm care Traditional pacemakers use leads to deliver energy to the heart, but those wires can fracture, cause infection, and limit effectiveness. Andrew, what problems do these traditional leads create, and how does EBR’s WiSE™ system remove them entirely? 2. Delivering a world-first wireless pacing breakthrough The WiSE™ implant, about the size of a grain of rice, delivers energy wirelessly inside the heart, a more natural and effective pacing location. It’s the only system in the world capable of leadless left-ventricular pacing. Can you explain what makes it stand out in the fast-moving leadless pacing market? 3. Capturing a US$3.6 billion global opportunity Pacemakers have been around for more than 60 years, but the market is now shifting rapidly to leadless devices, and EBR’s technology is positioned to capture significant share as adoption accelerates globally. How large is the global opportunity for EBR? 4. Driving commercial momentum through key catalysts With WiSE™ now cleared for use in the US, EBR is no longer dependent on third-party enforcement and is building commercial momentum. What key catalysts will drive growth as you expand in the US and beyond? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
EBR Systems Inc (ASX:EBR): Medical device company revolutionising heart failure treatment
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS40QTY5NjQzQkQzMjgwNjhD

EBR Systems Inc (ASX:EBR): Medical device company revolutionising heart failure treatment

Starpharma (ASX:SPL, US OTC:SPHRY) is an innovative biotechnology company with two decades of experience in advancing dendrimer technology from the lab to the patient. The company’s mission is to help patients with significant illnesses, such as cancer, achieve improved health outcomes and quality of life through the application of its unique dendrimer platform technology. Starpharma Chief Executive Officer, Cheryl Maley, joins Lel Smits from The Stock Network. 1. Quarterly highlights: Major partnership wins This quarter was a milestone period for Starpharma, securing two major global partnerships with Genentech and Radiopharm Theranostics, demonstrating growing industry validation and commercial traction for Starpharma’s DEP® platform. How do these achievements position Starpharma for its next phase of growth? 2. Strategic partnerships and commercial momentum With Genentech providing access to world-leading oncology expertise and Radiopharm expanding into radiopharmaceuticals, Starpharma’s DEP® platform has gained powerful industry endorsement. How do these collaborations highlight the commercial power of the DEP® platform and what are your plans to maintain momentum? 3. Upcoming catalysts and FY26 focus Looking ahead, what key milestones and development programs will drive Starpharma’s growth and value creation through FY26? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
Starpharma (ASX:SPL, US OTC:SPHRY:SPL): Advancing dendrimer tech through partnerships & innovation
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS5DNTU3ODQ4ODAzMjFERTI1

Starpharma (ASX:SPL, US OTC:SPHRY:SPL): Advancing dendrimer tech through partnerships & innovation

Moab Minerals (ASX:MOM) is an Australian exploration company with a diversified portfolio of uranium, gold and copper assets. Moab Minerals has just announced the acquisition of Imbas Mining Pty Ltd, which holds the right to earn up to 80% of the Sasare Gold and Copper Project in Zambia. The project hosts both the historic Sasare Gold Mine, and a 10 km copper anomaly corridor to the north. The Stock Network's Lel Smits speaks with Moab's Managing Director Malcolm Day, and Geologist, Byron Dumpleton, who has been appointed as a consultant to Moab to assist with upcoming exploration, to discuss Moab Minerals' strategic expansion into Zambia and the opportunities ahead. 1. Sasare Project acquisition and exploration strategy Moab has announced the acquisition of Imbas Mining, giving the company access to Zambia’s Sasare Gold and Copper Project. How does this transaction position Moab to diversify and accelerate its growth in the gold and copper space? 2. Historic mine potential and near-term targets With the Sasare Gold Mine historically producing ~12,500 oz before operations ceased in 1942, what early exploration work is planned to assess the scale and continuity of mineralisation across the project area? 3. Geological prospectively and exploration model As a geologist and shareholder of Imbas, can you expand on the iron oxide copper gold (IOCG)-style exploration model being applied to Sasare: What are the key geological indicators suggesting this system could host significant gold and copper resources? 4. Technical and operational outlook You previously served as Chief Geologist at Red 5 Limited (ASX:RED) before the merger with Silver Lake Resources (ASX:SLR) along with Senior roles with Straits Resources, Newcrest, WMC and your junior years with KCGM. How are you applying that major gold and copper systems experience to shape Moab Minerals' (ASX:MOM) exploration? _ _ _ Subscribe to TSN's YouTube channel for the latest stock content: https://www.youtube.com/channel/UCEEVNCMFSRxFa0Bb2wKLS0g?sub_confirmation=1 _ _ _ Follow TSN for the latest stock news and interviews: Twitter: https://twitter.com/thestocknet Instagram: https://www.instagram.com/thestocknetwork/ LinkedIn: https://www.linkedin.com/company/the-stock-network/ TikTok: https://www.tiktok.com/@thestocknet?lang=en Facebook: https://www.facebook.com/TheStockNet/ _ _ _ Connect with our host Lel Smits online - @LelSmits - Twitter / X: https://twitter.com/lelsmits - Instagram: https://www.instagram.com/lelsmits/ - LinkedIn: https://www.linkedin.com/in/leldesmits/ - TikTok: https://www.tiktok.com/@lelsmits?lang=en - Facebook: https://m.facebook.com/lelsmits/ - Threads: https://www.threads.net/@lelsmits _ _ _ Disclaimer The material contained in this post is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice. We give no warranty to the accuracy, reliability or completeness of information that is contained in this post and exclude liability for any loss. This post may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever. We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this post. Please see The Stock Network website for our full content disclaimer. _ _ _ Visit TSN's website to sign up for regular stock updates: www.thestocknetwork.com.au _ _ _
Moab Minerals (ASX:MOM): Expanding into gold and copper with Zambia’s historic Sasare Project
YouTube Video UExTblZqZ2VlMkp1ZTZJZFNvOHpPVlZYMVpkWUNwdXctVS4wMTIyMTBBMTA3RDUxNjlD

Moab Minerals (ASX:MOM): Expanding into gold and copper with Zambia’s historic Sasare Project

View More

Get the latest ASX stock market news delivered to your inbox

By proceeding, you can confirm you understand that we handle personal informational in accordance with our Privacy Policy